Trial Site Detail
Drug: |
IPI-493 |
|||
|---|---|---|---|---|
Trial: |
A Phase I Dose Escation Study of IPI-493 |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Terminated |
|||
Premier Oncology, Scottsdale9023 E. Desert Cove Ave. Suite 101 |
Principal Investigator: |
David Mendelson, M.D. |
|---|---|
Contact: |
Patricia Shannon, RN 480 860-5000 xt 223 pshannon@premiereoncology.com |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Premier Oncology, Scottsdale Website: |
http://www.premiereoncology.com/po/index.php?option=com_content&task=category§ionid=4&id=67&Itemid=55 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.